Items 1 to 10 of about 371295
1. Feinberg T, Lilly C, Innes K: Nonvitamin, Nonmineral Dietary Supplement Use among Adults with Fibromyalgia: United States, 2007-2012. Evid Based Complement Alternat Med; 2017;2017:6751856
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nonvitamin, Nonmineral Dietary Supplement Use among Adults with Fibromyalgia: United States, 2007-2012.
  • METHODS: Data were drawn from 2007 and 2012 National Health Interview Surveys (<i>N</i>'s = 20127 and 30672, resp.).
  • Logistic regression was used to examine associations of FMS to NVNM use (past 12 months) and evaluate potential modifying influences of gender and comorbidities.
  • RESULTS: FMS was significantly higher in 2012 than in 2007 (1.7% versus 1.3%), whereas NVNM use decreased (57% versus 41%; <i>p</i> < 0.0001).
  • Adults reporting diagnosis were more likely to use NVNMs within 12 months, 30 days, or ever relative to adults without; positive associations remained significant after controlling for demographics, lifestyle characteristics, medical history, and other confounders (ranges: 2007 and 2012 AORs = 2.3-2.7; 1.5-1.6, resp.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arthritis Care Res (Hoboken). 2013 May;65(5):786-92 [23203795.001]
  • [Cites] Clin Exp Rheumatol. 2011 Nov-Dec;29(6 Suppl 69):S79-87 [22243553.001]
  • [Cites] J Rheumatol. 2011 Jun;38(6):1113-22 [21285161.001]
  • [Cites] Clin Rheumatol. 1996 Sep;15(5):478-82 [8894361.001]
  • [Cites] J Gen Intern Med. 2014 Jan;29(1):110-8 [24030427.001]
  • [Cites] Curr Rheumatol Rep. 2011 Dec;13(6):513-20 [21833699.001]
  • [Cites] J Clin Rheumatol. 2013 Mar;19(2):72-7 [23364665.001]
  • [Cites] Natl Health Stat Report. 2008 Dec 10;(12):1-23 [19361005.001]
  • [Cites] Natl Health Stat Report. 2016 Oct;(98 ):1-12 [27736632.001]
  • [Cites] Rheumatol Int. 2011 Nov;31(11):1403-8 [21476098.001]
  • [Cites] BMC Musculoskelet Disord. 2007 Mar 09;8:27 [17349056.001]
  • [Cites] J Pain. 2015 Nov;16(11):1147-62 [26320946.001]
  • [Cites] Curr Pain Headache Rep. 2013 Aug;17(8):356 [23801009.001]
  • [Cites] Headache. 2009 Oct;49(9):1333-44 [19788473.001]
  • [Cites] Ann Rheum Dis. 2017 Feb;76(2):318-328 [27377815.001]
  • [Cites] Cochrane Database Syst Rev. 2012 Apr 18;(4):CD008294 [22513958.001]
  • [Cites] Pain Pract. 2011 Nov-Dec;11(6):516-27 [21199320.001]
  • [Cites] MMWR Recomm Rep. 2016 Mar 18;65(1):1-49 [26987082.001]
  • [Cites] Am J Public Health. 2009 Feb;99(2):221-7 [18799767.001]
  • [Cites] Pain Med. 2008 Nov;9(8):1065-72 [18564996.001]
  • [Cites] Medicine (Baltimore). 2015 Mar;94(10):e616 [25761187.001]
  • [Cites] J Womens Health (Larchmt). 2009 May;18(5):709-16 [19445618.001]
  • [Cites] BMC Complement Altern Med. 2007 May 16;7:15 [17506893.001]
  • [Cites] Cochrane Database Syst Rev. 2014 Jun 23;(6):CD010692 [24956205.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2016 Dec 30;65(5051):1445-1452 [28033313.001]
  • [Cites] Expert Rev Clin Immunol. 2013 Nov;9(11):1069-76 [24168413.001]
  • [Cites] Pain Pract. 2011 May-Jun;11(3):204-16 [20807351.001]
  • [Cites] Arthritis Res Ther. 2014 Jan 17;16(1):201 [24433463.001]
  • [Cites] J Rheumatol. 2010 Feb;37(2):305-15 [20080915.001]
  • [Cites] Mayo Clin Proc. 2015 May;90(5):680-92 [25939940.001]
  • [Cites] Am J Gastroenterol. 2009 Mar;104(3):728-38 [19240698.001]
  • [Cites] PLoS One. 2015 Sep 17;10(9):e0138024 [26379048.001]
  • (PMID = 28811828.001).
  • [ISSN] 1741-427X
  • [Journal-full-title] Evidence-based complementary and alternative medicine : eCAM
  • [ISO-abbreviation] Evid Based Complement Alternat Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


2. Wanzira H, Katamba H, Okullo AE, Agaba B, Kasule M, Rubahika D: Factors associated with malaria parasitaemia among children under 5 years in Uganda: a secondary data analysis of the 2014 Malaria Indicator Survey dataset. Malar J; 2017 May 08;16(1):191
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Factors associated with malaria parasitaemia among children under 5 years in Uganda: a secondary data analysis of the 2014 Malaria Indicator Survey dataset.
  • METHODS: This is a secondary data analysis of the 2014 Malaria Indicator Survey dataset of children under 5 years.
  • Malaria parasite prevalence significantly increased from 11.08 (95% CI 9.12-13.40) among children with no anaemia to 50.99% (95% CI 39.13-62.74) with severe anaemia (Chi-square p-value = 0.001).
  • Additionally, prevalence significantly rose from the youngest age group (under 6 months) by 1.62 times (95% CI 1.04-2.52, p = 0.033) among the age group of 7-12 months and to four times (95% CI 2.57-6.45, p = 0.001) among those who were between 49 and 59 months.
  • The following were associated with reduced parasitaemia: IRS use (AOR 0.23 [0.08-0.61], p = 0.004), educated mothers (primary AOR 0.75 [0.59-0.96], p = 0.023 to tertiary AOR 0.11 [0.02-0.53], 0.006), mother heard malaria message (AOR 0.78 [0.62-0.99], p = 0.037), and wealthier households (richest AOR 0.17 [0.08-0.36], p = 0.001).
  • Designing interventions that include the use of IRS and behaviour change communication tailored to include older children, especially in areas with high malaria prevalence, could be of added value.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] PLoS One. 2010 Jul 21;5(7):e11692 [20657782.001]
  • [Cites] Malar J. 2014 Jan 02;13:1 [24383426.001]
  • [Cites] Parasitol Today. 2000 Nov;16(11):469-76 [11063857.001]
  • [Cites] Lancet. 2011 Dec 17;378(9809):2123-35 [21813172.001]
  • [Cites] PLoS One. 2015 Jul 24;10(7):e0134061 [26207758.001]
  • [Cites] Clin Infect Dis. 2017 Mar 24;:null [28369387.001]
  • [Cites] Curr Opin Hematol. 2003 Mar;10(2):108-14 [12579035.001]
  • [Cites] Trop Med Int Health. 2000 Jan;5(1):9-16 [10672200.001]
  • [Cites] Malar J. 2006 Jan 26;5:5 [16436216.001]
  • [Cites] Trop Med Int Health. 1997 Feb;2(2):165-78 [9472302.001]
  • [Cites] Am J Trop Med Hyg. 2003 Apr;68(4 Suppl):68-77 [12749488.001]
  • [Cites] Malar J. 2012 Dec 27;11:432 [23270614.001]
  • [Cites] Curr Opin Microbiol. 2006 Aug;9(4):388-94 [16815736.001]
  • [Cites] Trop Med Int Health. 2014 Nov;19(11):1294-309 [25145389.001]
  • [Cites] Malar J. 2011 May 18;10:134 [21592380.001]
  • [Cites] Am J Trop Med Hyg. 2013 May;88(5):855-61 [23458956.001]
  • [Cites] Malar J. 2009 May 07;8:95 [19422704.001]
  • [Cites] Am J Trop Med Hyg. 2006 Dec;75(6):1223-31 [17172397.001]
  • [Cites] Pan Afr Med J. 2012;13 Suppl 1:2 [23467840.001]
  • [Cites] Am J Trop Med Hyg. 1999 Sep;61(3):431-8 [10497986.001]
  • [Cites] Am J Trop Med Hyg. 2007 Dec;77(6 Suppl):170-80 [18165490.001]
  • [Cites] Trop Med Int Health. 2015 Dec;20(12):1745-55 [26427024.001]
  • [Cites] Bull Mem Acad R Med Belg. 2000;155(5-6):218-26 [11304957.001]
  • [Cites] Trop Med Int Health. 2004 Oct;9(10):1050-65 [15482397.001]
  • [Cites] PLoS One. 2015 Jan 30;10(1):e0117396 [25635688.001]
  • [Cites] Am J Trop Med Hyg. 2004 Aug;71(2 Suppl):25-34 [15331816.001]
  • [Cites] Soc Sci Med. 2006 Jul;63(1):103-6 [16448735.001]
  • [Cites] BMC Infect Dis. 2013 Mar 05;13:123 [23497273.001]
  • [Cites] Acta Trop. 2012 Mar;121(3):184-95 [21420377.001]
  • [Cites] Lancet. 2013 Sep 14;382(9896):963-72 [23790353.001]
  • [Cites] PLoS One. 2015 Mar 13;10(3):e0118901 [25768015.001]
  • [Cites] PLoS One. 2012;7(8):e42857 [22880123.001]
  • (PMID = 28482832.001).
  • [ISSN] 1475-2875
  • [Journal-full-title] Malaria journal
  • [ISO-abbreviation] Malar. J.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Anaemia / Children under 5 years / Malaria parasitaemia
  •  go-up   go-down


3. Yang Q, Zhang H, Wang Y, Xu Z, Zhang G, Chen X, Xu Y, Cao B, Kong H, Ni Y, Yu Y, Sun Z, Hu B, Huang W, Wang Y, Wu A, Feng X, Liao K, Luo Y, Hu Z, Chu Y, Lu J, Su J, Gui B, Duan Q, Zhang S, Shao H, Badal RE: Antimicrobial susceptibilities of aerobic and facultative gram-negative bacilli isolated from Chinese patients with urinary tract infections between 2010 and 2014. BMC Infect Dis; 2017 Mar 06;17(1):192
MedlinePlus Health Information. consumer health - Urinary Tract Infections.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Antimicrobial susceptibilities of aerobic and facultative gram-negative bacilli isolated from Chinese patients with urinary tract infections between 2010 and 2014.
  • METHODS: From 2010 to 2014, the minimum inhibitory concentrations (MICs) of 12 antibiotics for 4,332 aerobic and facultative Gram-negative bacilli, sampled in 21 hospitals in 16 cities, were determined by the broth microdilution method.
  • RESULTS: Enterobacteriaceae composed 88.5% of the total isolates, with Escherichia coli (E. coli) (63.2%) the most commonly isolated species, followed by Klebsiella pneumoniae (K. pneumoniae) (12.2%).
  • Non-Enterobacteriaceae accounted for only 11.5% of all isolates and included mainly Pseudomonas aeruginosa (P. aeruginosa) (6.9%) and Acinetobacter baumannii (A. baumannii) (3.3%).
  • Although non-Enterobacteriaceae did not show high susceptibilities to the 12 common antibiotics, amikacin exhibited the highest in vitro activity against P. aeruginosa over the 5-year study period, followed by piperacillin-tazobactam, imipenem, ceftazidime, cefepime, ciprofloxacin, and levofloxacin.
  • The Extended Spectrum Beta-Lactamase (ESBL) rates decreased slowly during the 5 years in E. coli from 68.6% in 2010 to 59.1% in 2014, in K. pneumoniae from 59.7 to 49.2%, and in Proteus mirabilis (P. mirabilis) from 40.0 to 26.1%.

  • MedlinePlus Health Information. consumer health - Antibiotic Resistance.
  • MedlinePlus Health Information. consumer health - Antibiotics.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Antimicrob Chemother. 2007 Jan;59(1):110-3 [17090552.001]
  • [Cites] Rev Esp Quimioter. 2008 Sep;21(3):166-73 [18792817.001]
  • [Cites] Euro Surveill. 2008 Jan 24;13(4):null [18445397.001]
  • [Cites] Clin Infect Dis. 2011 Mar 1;52(5):e103-20 [21292654.001]
  • [Cites] Antimicrob Agents Chemother. 2001 May;45(5):1515-21 [11302820.001]
  • [Cites] Int J Antimicrob Agents. 2009 Dec;34(6):585-8 [19748234.001]
  • [Cites] J Chemother. 2009 Dec;21(6):661-5 [20071290.001]
  • [Cites] FEMS Microbiol Lett. 2000 Sep 15;190(2):181-4 [11034276.001]
  • [Cites] BMC Infect Dis. 2015 Oct 13;15:414 [26464143.001]
  • [Cites] Antimicrob Agents Chemother. 2002 Mar;46(3):630-7 [11850241.001]
  • [Cites] World J Urol. 2013 Dec;31(6):1427-32 [23358791.001]
  • [Cites] Urology. 2009 Sep;74(3):702-7 [19362346.001]
  • [Cites] J Infect. 2009 Mar;58(3):213-9 [19246099.001]
  • [Cites] Lancet Infect Dis. 2013 Feb;13(2):155-65 [23347633.001]
  • [Cites] Microb Drug Resist. 2006 Winter;12(4):257-64 [17227211.001]
  • [Cites] Antimicrob Agents Chemother. 2001 Oct;45(10):2831-7 [11557477.001]
  • [Cites] Antimicrob Agents Chemother. 2006 Oct;50(10):3396-406 [17005822.001]
  • [Cites] Infect Immun. 1998 Feb;66(2):645-9 [9453621.001]
  • [Cites] Ann Clin Lab Sci. 2016 Jul;46(4):393-400 [27466299.001]
  • [Cites] Clin Microbiol Infect. 2000 Sep;6(9):460-3 [11168179.001]
  • [Cites] Am J Infect Control. 2015 Apr 1;43(4):358-64 [25838134.001]
  • [Cites] Infect Dis Clin North Am. 2014 Mar;28(1):149-59 [24484581.001]
  • [Cites] Arch Intern Med. 2005 Jun 27;165(12):1430-5 [15983294.001]
  • [Cites] Clin Infect Dis. 2009 Sep 1;49(5):682-90 [19622043.001]
  • [Cites] Pharm World Sci. 2008 Dec;30(6):787-93 [18493864.001]
  • [Cites] Clin Microbiol Infect. 2008 Jan;14 Suppl 1:159-65 [18154540.001]
  • [Cites] Eur J Clin Microbiol Infect Dis. 2015 Apr;34(4):795-803 [25487131.001]
  • [Cites] Clin Microbiol Infect. 2008 Jan;14 Suppl 1:134-43 [18154537.001]
  • [Cites] Infect Dis Clin North Am. 2014 Mar;28(1):1-13 [24484571.001]
  • [Cites] Antimicrob Agents Chemother. 2010 Jan;54(1):573-7 [19805565.001]
  • [Cites] Antimicrob Agents Chemother. 2003 Feb;47(2):790-3 [12543694.001]
  • [Cites] BMJ Open. 2013 Dec 13;3(12):e004152 [24334199.001]
  • [Cites] Infect Dis (Lond). 2016;48(3):241-5 [26523346.001]
  • [Cites] Int J Antimicrob Agents. 2015 May;45(5):485-90 [25600890.001]
  • (PMID = 28264656.001).
  • [ISSN] 1471-2334
  • [Journal-full-title] BMC infectious diseases
  • [ISO-abbreviation] BMC Infect. Dis.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents
  • [Keywords] NOTNLM ; Antimicrobial resistance / Carbapenems / Extended spectrum beta-lactamases (ESBLs) / Urinary tract infections
  •  go-up   go-down


4. Kim JW, Kwak SG, Lee H, Kim SK, Choe JY, Park SH: Prevalence and incidence of gout in Korea: data from the national health claims database 2007-2015. Rheumatol Int; 2017 Jul 04;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prevalence and incidence of gout in Korea: data from the national health claims database 2007-2015.
  • Patients who had at least one claim for gout between 2007 and 2015 were included in the study.
  • The prevalence of gout from 2007 to 2015 and the incidence of gout from 2009 to 2015 were determined.
  • The prevalence of gout (95% CI) increased from 3.49 (3.48-3.51) per 1000 persons in 2007 to 7.58 (7.55-7.60) per 1000 persons in 2015.
  • The prevalence and incidence of gout increased in Korea between 2007 and 2015.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] N Engl J Med. 2004 Mar 11;350(11):1093-103 [15014182.001]
  • [Cites] Arthritis Rheum. 2010 Apr;62(4):1069-76 [20131266.001]
  • [Cites] BMJ. 2008 Feb 9;336(7639):309-12 [18244959.001]
  • [Cites] Joint Bone Spine. 2015 Jan;82(1):45-51 [25238950.001]
  • [Cites] Joint Bone Spine. 2017 Jan;84(1):59-64 [27236260.001]
  • [Cites] J Rheumatol. 2008 Sep;35(9):1859-64 [18634142.001]
  • [Cites] J Clin Rheumatol. 2004 Dec;10(6):308-14 [17043538.001]
  • [Cites] Am J Epidemiol. 2014 Mar 1;179(5):576-83 [24335384.001]
  • [Cites] JAMA. 1991 Dec 4;266(21):3004-7 [1820473.001]
  • [Cites] Br J Rheumatol. 1998 Mar;37(3):258-62 [9566664.001]
  • [Cites] J Korean Med Sci. 2005 Dec;20(6):1029-33 [16361817.001]
  • [Cites] Ann Rheum Dis. 2015 Apr;74(4):661-7 [24431399.001]
  • [Cites] Lancet. 2004 Apr 17;363(9417):1277-81 [15094272.001]
  • [Cites] J Rheumatol. 2006 Jul;33(7):1346-50 [16821269.001]
  • [Cites] Ann Rheum Dis. 2013 May;72(5):694-700 [22736095.001]
  • [Cites] Ann Rheum Dis. 2012 Jun;71(6):924-8 [22172492.001]
  • [Cites] Rheumatol Int. 2014 Jul;34(7):909-17 [24322455.001]
  • [Cites] Ann Rheum Dis. 2009 Nov;68(11):1728-33 [19029167.001]
  • [Cites] Ann Rheum Dis. 2015 Feb;74(2):369-74 [24265412.001]
  • [Cites] Acta Endocrinol (Copenh). 1977 May;85(1):198-208 [577077.001]
  • [Cites] Arch Intern Med. 2005 Apr 11;165(7):742-8 [15824292.001]
  • [Cites] Ann Rheum Dis. 1997 Jan;56(1):22-6 [9059136.001]
  • [Cites] Ophthalmology. 2015 Oct;122(10):2063-70.e1 [26208437.001]
  • [Cites] J Rheumatol. 2002 Nov;29(11):2403-6 [12415600.001]
  • [Cites] Arthritis Res Ther. 2016 Jul 13;18:164 [27412614.001]
  • [Cites] Arthritis Res Ther. 2011 Mar 03;13(2):R39 [21371293.001]
  • [Cites] PLoS One. 2014 Oct 16;9(10):e110650 [25329714.001]
  • [Cites] Arthritis Res Ther. 2006;8 Suppl 1:S2 [16820041.001]
  • [Cites] Arthritis Res Ther. 2015 Jan 23;17:13 [25612613.001]
  • [Cites] Ann Rheum Dis. 2010 Jul;69(7):1305-9 [19592386.001]
  • [Cites] Ann Rheum Dis. 2005 Feb;64(2):267-72 [15647434.001]
  • [Cites] Arthritis Rheum. 2011 Oct;63(10):3136-41 [21800283.001]
  • [Cites] Arthritis Care Res (Hoboken). 2016 Feb;68(2):261-6 [26234279.001]
  • (PMID = 28676911.001).
  • [ISSN] 1437-160X
  • [Journal-full-title] Rheumatology international
  • [ISO-abbreviation] Rheumatol. Int.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Keywords] NOTNLM ; Gout / Incidence / Korea / Prevalence
  •  go-up   go-down


5. Jasseh M, Howie SRC, Gomez P, Scott S, Roca A, Cham M, Greenwood B, Corrah T, D'Alessandro U: Disease-specific mortality burdens in a rural Gambian population using verbal autopsy, 1998-2007. Glob Health Action; 2014 Dec;7(1):25598
HIV InSite. treatment guidelines - Malaria and HIV .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Disease-specific mortality burdens in a rural Gambian population using verbal autopsy, 1998-2007.
  • Objective To estimate and evaluate the cause-of-death structure and disease-specific mortality rates in a rural area of The Gambia as determined using the InterVA-4 model.
  • Design Deaths and person-years of observation were determined by age group for the population of the Farafenni Health and Demographic Surveillance area from January 1998 to December 2007.
  • Results A total of 3,203 deaths were recorded and VA administered for 2,275 (71%).
  • All-age mortality declined from 15 per 1,000 person-years in 1998-2001 to 8 per 1,000 person-years in 2005-2007.
  • Communicable diseases accounted for half (49.9%) of the deaths in all age groups, dominated by acute respiratory infections (ARI) (13.7%), malaria (12.9%) and pulmonary tuberculosis (10.2%).
  • The leading causes of death among infants were ARI (5.59 per 1,000 person-years [95% CI: 4.38-7.15]) and malaria (4.11 per 1,000 person-years [95% CI: 3.09-5.47]).
  • Stroke-related mortality increased to become the leading cause of death among the elderly aged 60 years or more in 2005-2007.
  • Conclusions Mortality in the Farafenni HDSS area was dominated by communicable diseases.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28672451.001).
  • [ISSN] 1654-9880
  • [Journal-full-title] Global health action
  • [ISO-abbreviation] Glob Health Action
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Farafenni / The Gambia / cause of death / communicable disease / disease-specific mortality / mortality / non-communicable disease / verbal autopsy
  •  go-up   go-down


6. He J, Xie Y, Kong S, Qiu W, Wang X, Wang D, Sun X, Sun D: Psychomotor retardation with a 1q42.11-q42.12 deletion. Hereditas; 2017;154:6
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Psychomotor retardation with a 1q42.11-q42.12 deletion.
  • A 1q42 deletion is a rare structure variation that commonly harbours various deletion breakpoints along with diversified phenotypes.
  • A 1.9 Mb deletion located within 1q42.11-q42.12 was validated at the molecular cytogenetic level.
  • This is the first report of a 1q42.11-q42.12 deletion in a patient with onlypsychomotor retardation.

  • MedlinePlus Health Information. consumer health - Developmental Disabilities.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Med Genet A. 2015 Jun;167(6):1418-20 [25900767.001]
  • [Cites] Am J Med Genet A. 2010 Oct;152A(10):2493-504 [20799323.001]
  • [Cites] Nat Genet. 2007 Jun;39(6):721-3 [17529978.001]
  • [Cites] Clin Genet. 2010 Apr;77(4):404-7 [20095987.001]
  • [Cites] Am J Med Genet A. 2013 Aug;161A(8):2066-73 [23824842.001]
  • [Cites] Genet Med. 2007 Sep;9(9):607-16 [17873649.001]
  • [Cites] Br J Psychiatry. 1976 Dec;129:592-7 [1000144.001]
  • [Cites] RNA. 2010 May;16(5):969-79 [20348448.001]
  • [Cites] Eur J Med Genet. 2013 Jun;56(6):309-13 [23542665.001]
  • [Cites] Eur Neuropsychopharmacol. 2014 Oct;24(10):1630-40 [25129432.001]
  • [Cites] Am J Med Genet A. 2014 Feb;164A(2):441-8 [24357076.001]
  • [Cites] Prog Neuropsychopharmacol Biol Psychiatry. 2015 Oct 1;62:7-13 [25891250.001]
  • [Cites] Mol Biol Cell. 2004 Dec;15(12):5712-23 [15469983.001]
  • [Cites] Cancer Res. 2005 Jul 1;65(13):5561-70 [15994928.001]
  • [Cites] J Biol Chem. 1994 Apr 15;269(15):11312-7 [8157663.001]
  • [Cites] Science. 2005 Mar 4;307(5714):1434-40 [15637236.001]
  • [Cites] Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):395-409 [21044654.001]
  • [Cites] Am J Med Genet A. 2006 Aug 1;140(15):1637-43 [16835927.001]
  • [Cites] Neuroscience. 2009 Oct 6;163(2):646-61 [19540314.001]
  • [Cites] Hum Mutat. 2008 Sep;29(9):1118-24 [18570184.001]
  • [Cites] J Proteome Res. 2008 Jul;7(7):2959-72 [18549262.001]
  • [Cites] Biochem Biophys Res Commun. 2015 Aug 28;464(3):780-6 [26166824.001]
  • [Cites] J Cell Sci. 2016 Jan 1;129(1):51-64 [26604221.001]
  • [Cites] Am J Med Genet A. 2006 Jan 1;140(1):17-23 [16333846.001]
  • [Cites] Biochem J. 1974 Apr;139(1):77-88 [4463951.001]
  • [Cites] Am J Psychiatry. 2001 Feb;158(2):314-6 [11156819.001]
  • [Cites] J Med Genet. 2010 Jun;47(6):361-70 [20522425.001]
  • [Cites] J Affect Disord. 1995 Dec 13;35(3):107-15 [8749838.001]
  • [Cites] CNS Spectr. 2003 Aug;8(8 Suppl 1):53-61 [14767398.001]
  • [Cites] Eur J Hum Genet. 2006 Sep;14(9):999-1008 [16736036.001]
  • [Cites] Nucleus. 2010 Mar-Apr;1(2):179-89 [21326950.001]
  • [Cites] Am J Psychiatry. 2005 Jun;162(6):1066 [15930053.001]
  • [Cites] Annu Rev Genomics Hum Genet. 2009;10:451-81 [19715442.001]
  • [Cites] Genomics. 1998 Dec 15;54(3):469-76 [9878250.001]
  • [Cites] EMBO Mol Med. 2013 Jul;5(7):1067-86 [23776131.001]
  • [Cites] Eur J Neurosci. 2006 Apr;23(8):2027-34 [16630050.001]
  • [Cites] Am J Med Genet A. 2010 Apr;152A(4):987-93 [20358614.001]
  • [Cites] J Affect Disord. 2004 Dec;83(2-3):109-20 [15555703.001]
  • [Cites] Biochem Biophys Res Commun. 2006 Aug 4;346(3):1075-82 [16782053.001]
  • [Cites] Psychol Med. 2000 May;30(3):565-70 [10883712.001]
  • (PMID = 28286461.001).
  • [ISSN] 1601-5223
  • [Journal-full-title] Hereditas
  • [ISO-abbreviation] Hereditas
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; 1q42 deletion (major topic) / Genotype-phenotype correlation (major topic) / Microarray analysis (major topic) / Psychomotor retardation (major topic)
  •  go-up   go-down


7. Boudon SM, Vuorinen A, Geotti-Bianchini P, Wandeler E, Kratschmar DV, Heidl M, Campiche R, Jackson E, Odermatt A: Novel 11β-hydroxysteroid dehydrogenase 1 inhibitors reduce cortisol levels in keratinocytes and improve dermal collagen content in human ex vivo skin after exposure to cortisone and UV. PLoS One; 2017;12(2):e0171079
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] 11-beta-Hydroxysteroid Dehydrogenase Type 1 / antagonists & inhibitors. Collagen / metabolism. Hydrocortisone / metabolism. Keratinocytes / drug effects. Keratinocytes / metabolism. Skin / drug effects. Skin / metabolism

  • Hazardous Substances Data Bank. HYDROCORTISONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Med Chem. 2014 Jul 24;57(14):5995-6007 [24960438.001]
  • [Cites] Nucleic Acids Res. 2000 Jan 1;28(1):235-42 [10592235.001]
  • [Cites] Drug Metab Rev. 2012 May;44(2):173-91 [22181347.001]
  • [Cites] Endocr Rev. 2013 Dec;34(6):827-84 [23939821.001]
  • [Cites] J Invest Dermatol. 2015 Jun;135(6):1638-48 [25317845.001]
  • [Cites] PLoS One. 2014 Mar 25;9(3):e93051 [24667799.001]
  • [Cites] J Endocrinol. 2003 Sep;178(3):331-7 [12967326.001]
  • [Cites] Mol Cell Endocrinol. 2012 Mar 24;350(2):168-86 [21820034.001]
  • [Cites] J Invest Dermatol. 2007 Dec;127(12):2749-58 [17657244.001]
  • [Cites] J Cell Biochem. 2011 Jun;112(6):1499-505 [21344493.001]
  • [Cites] J Invest Dermatol. 2011 Jan;131(1):30-6 [20739946.001]
  • [Cites] Br J Dermatol. 2013 Mar;168(3):595-601 [23363016.001]
  • [Cites] J Neuroinflammation. 2012 Nov 28;9:260 [23190711.001]
  • [Cites] Horm Res. 2000;54(5-6):218-29 [11595810.001]
  • [Cites] Br J Dermatol. 2002 Nov;147(5):859-68 [12410694.001]
  • [Cites] J Clin Invest. 2013 Jul;123(7):3051-60 [23722901.001]
  • [Cites] Endocr Rev. 2004 Oct;25(5):831-66 [15466942.001]
  • [Cites] Am J Physiol Endocrinol Metab. 2005 Apr;288(4):E701-6 [15572653.001]
  • [Cites] J Clin Endocrinol Metab. 1996 Jul;81(7):2746-9 [8675607.001]
  • [Cites] Mol Cell Endocrinol. 2003 Dec 30;212(1-2):41-9 [14654249.001]
  • [Cites] Am J Physiol Endocrinol Metab. 2011 Sep;301(3):E484-93 [21673307.001]
  • [Cites] J Photochem Photobiol B. 1989 Oct;4(1):1-13 [2509656.001]
  • [Cites] J Neuroimmunol. 2005 May;162(1-2):97-102 [15833364.001]
  • [Cites] J Steroid Biochem Mol Biol. 2013 Sep;137:107-23 [23435015.001]
  • [Cites] Fitoterapia. 2009 Apr;80(3):200-5 [19535018.001]
  • [Cites] Skin Pharmacol Appl Skin Physiol. 2002 Mar-Apr;15(2):85-91 [11867964.001]
  • [Cites] J Invest Dermatol. 1979 Jul;73(1):59-66 [448178.001]
  • [Cites] J Med Chem. 2002 Aug 29;45(18):3813-5 [12190302.001]
  • [Cites] Clin Sci (Lond). 1998 Jun;94(6):557-72 [9854452.001]
  • [Cites] J Med Chem. 2014 Jun 12;57(11):4466-86 [24294985.001]
  • [Cites] FEBS J. 2010 May;277(10):2375-86 [20423462.001]
  • [Cites] J Invest Dermatol. 1991 Apr;96(4):484-9 [2007786.001]
  • [Cites] Exp Dermatol. 2010 Aug;19(8):757-9 [20659158.001]
  • [Cites] Mol Carcinog. 2007 Aug;46(8):732-40 [17538956.001]
  • [Cites] PLoS One. 2011;6(9):e25039 [21949844.001]
  • [Cites] Bioorg Med Chem. 2012 Feb 15;20(4):1557-68 [22285569.001]
  • [Cites] FEBS Lett. 2004 Sep 10;574(1-3):167-70 [15358559.001]
  • [Cites] Arch Dermatol Res. 1998 Jul;290(7):388-93 [9749994.001]
  • [Cites] Skin Pharmacol. 1997;10(5-6):261-4 [9449164.001]
  • [Cites] J Biol Chem. 2007 Feb 9;282(6):4021-34 [17095510.001]
  • [Cites] Curr Top Med Chem. 2011;11(12):1464-75 [21510838.001]
  • [Cites] Am J Pathol. 2006 Jun;168(6):1861-8 [16723701.001]
  • [Cites] Mol Cell Endocrinol. 2007 Sep 15;275(1-2):71-8 [17630118.001]
  • [Cites] Pigment Cell Res. 2006 Dec;19(6):606-14 [17083487.001]
  • [Cites] Photochem Photobiol Sci. 2013 Jan;12(1):54-64 [23111621.001]
  • [Cites] Arch Dermatol Res. 2010 Jan;302(1):5-17 [19756672.001]
  • [Cites] J Invest Dermatol. 1992 Feb;98(2):220-5 [1732386.001]
  • (PMID = 28152550.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Amides; 0 / Enzyme Inhibitors; 9007-34-5 / Collagen; EC 1.1.1.146 / 11-beta-Hydroxysteroid Dehydrogenase Type 1; EC 1.1.1.146 / HSD11B1 protein, human; V27W9254FZ / Cortisone; WI4X0X7BPJ / Hydrocortisone
  •  go-up   go-down


8. Shu X, Ping M, Yin G, Jiang M: Investigation of Helicobacter &lt;i&gt;pylori&lt;/i&gt; infection among symptomatic children in Hangzhou from 2007 to 2014: a retrospective study with 12,796 cases. PeerJ; 2017;5:e2937

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Investigation of Helicobacter <i>pylori</i> infection among symptomatic children in Hangzhou from 2007 to 2014: a retrospective study with 12,796 cases.
  • METHODS: A systematic surveillance of H. <i>pylori</i> infection according to the <sup>13</sup>C-urea breath test was conducted from January 2007 to December 2014 in the Children's hospital, Zhejiang University School of Medicine.
  • RESULTS: A total of 12,796 subjects were recruited and 18.6% children evaluated as H. <i>pylori</i> positive.
  • The annual positive rates decreased from 2007 to 2014 (<i>χ</i><sup>2</sup> = 20.461, <i>p</i> < 0.01).
  • The positive rates were 14.8%, 20.2% and 25.8% in 3-6, 7-11 and 12-17 years age group respectively, which increased with age (<i>χ</i><sup>2</sup> = 116.002, <i>p</i> < 0.01).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Helicobacter. 2009 Sep;14 Suppl 1:52-7 [19712169.001]
  • [Cites] Can J Gastroenterol. 2005 Jul;19(7):399-408 [16010300.001]
  • [Cites] Dig Dis Sci. 2008 Oct;53(10):2650-6 [18270835.001]
  • [Cites] Gastroenterol Res Pract. 2011;2011:940650 [21826138.001]
  • [Cites] Eur J Pediatr. 2010 Jan;169(1):15-25 [19618211.001]
  • [Cites] Helicobacter. 2007 Apr;12(2):164-9 [17309754.001]
  • [Cites] Helicobacter. 2009 Apr;14(2):128-33 [19298340.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2000 Feb;30(2):207-13 [10697142.001]
  • [Cites] Eur J Pediatr. 2013 Nov;172(11):1427-34 [23015042.001]
  • [Cites] Zhonghua Yi Xue Za Zhi. 2009 Oct 20;89(38):2682-5 [20137267.001]
  • [Cites] Helicobacter. 2012 Oct;17(5):369-73 [22967120.001]
  • [Cites] Gut Pathog. 2016 Mar 15;8:8 [26981156.001]
  • [Cites] Zhongguo Dang Dai Er Ke Za Zhi. 2012 Sep;14(9):675-7 [22989437.001]
  • [Cites] Helicobacter. 2008 Jun;13(3):219-24 [18466397.001]
  • [Cites] J Clin Invest. 2009 Sep;119(9):2475-87 [19729845.001]
  • [Cites] Helicobacter. 2008 Apr;13(2):157-65 [18321305.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2011 Aug;53(2):230-43 [21558964.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2007 Oct;45(4):428-32 [18030208.001]
  • [Cites] Indian J Gastroenterol. 2014 Jul;33(4):375-82 [24777895.001]
  • [Cites] Gastroenterology. 2006 Jan;130(1):65-72; quiz 211 [16401469.001]
  • [Cites] Helicobacter. 2015 Sep;20 Suppl 1:47-53 [26372825.001]
  • [Cites] Helicobacter. 2014 Sep;19 Suppl 1:1-5 [25167938.001]
  • [Cites] Aliment Pharmacol Ther. 2015 Oct;42(8):1019-26 [26271484.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2006 Apr;42(4):398-404 [16641578.001]
  • [Cites] Helicobacter. 2012 Feb;17(1):23-9 [22221612.001]
  • [Cites] World J Gastroenterol. 2010 Nov 7;16(41):5181-94 [21049552.001]
  • [Cites] Dig Dis Sci. 2006 Dec;51(12):2292-301 [17089189.001]
  • [Cites] J Gastroenterol Hepatol. 2010 Mar;25(3):479-86 [20370726.001]
  • [Cites] Pediatrics. 2010 Mar;125(3):e651-69 [20156901.001]
  • [Cites] Chin Med J (Engl). 2009 Aug 5;122(15):1759-63 [19781321.001]
  • [Cites] Helicobacter. 2012 Sep;17 Suppl 1:1-8 [22958148.001]
  • [Cites] Can J Gastroenterol. 2006 Dec;20(12):770-4 [17171195.001]
  • [Cites] Helicobacter. 2015 Sep;20 Suppl 1:1-7 [26372818.001]
  • [Cites] Helicobacter. 2007 Jun;12(3):258-64 [17493007.001]
  • [Cites] Acta Paediatr. 2007 Jul;96(7):1047-9 [17524023.001]
  • (PMID = 28168109.001).
  • [ISSN] 2167-8359
  • [Journal-full-title] PeerJ
  • [ISO-abbreviation] PeerJ
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; 13C-urea breath test (13C-UBT) / Age / Children / Gastrointestinal symptoms / Gender / Helicobacter pylori (H. pylori)
  •  go-up   go-down


9. Moleta C, Campbell JP, Kalpathy-Cramer J, Chan RV, Ostmo S, Jonas K, Chiang MF, Imaging & Informatics in ROP Research Consortium: Plus Disease in Retinopathy of Prematurity: Diagnostic Trends in 2016 Versus 2007. Am J Ophthalmol; 2017 Apr;176:70-76

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Plus Disease in Retinopathy of Prematurity: Diagnostic Trends in 2016 Versus 2007.
  • METHODS: ROP experts were recruited in 2007 and 2016 to classify 34 wide-field fundus images of ROP as plus, pre-plus, or normal, coded as "3," "2," and "1," respectively, in the database.
  • Secondary outcomes included correlation on the relative ordering of the images in 2016 vs 2007, interexpert agreement, and intraexpert agreement.
  • RESULTS: The average score for each image was higher for 30 of 34 (88%) images in 2016 compared with 2007, influenced by fewer images classified as normal (P < .01), a similar number of pre-plus (P = .52), and more classified as plus (P < .01).
  • CONCLUSIONS: Despite good agreement between cohorts on relative disease severity ranking, the higher average score and classifications for each image demonstrate that experts are diagnosing pre-plus and plus disease at earlier stages of disease severity in 2016, compared with 2007.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Elsevier Inc. All rights reserved.
  • [Cites] Am J Ophthalmol. 2016 Mar;163:1-10 [26705094.001]
  • [Cites] Br J Ophthalmol. 2010 Mar;94(3):351-6 [19955195.001]
  • [Cites] Retina. 2010 Jun;30(6):958-65 [20168274.001]
  • [Cites] Ophthalmology. 2016 Nov;123(11):2338-2344 [27591053.001]
  • [Cites] Radiology. 2000 Apr;215(1):169-74 [10751483.001]
  • [Cites] Ophthalmology. 2012 Dec;119(12):2644-5.e1-2 [23207022.001]
  • [Cites] Arch Ophthalmol. 2005 Jul;123(7):991-9 [16009843.001]
  • [Cites] Ophthalmology. 2016 Aug;123(8):1795-801 [27238376.001]
  • [Cites] JAMA Ophthalmol. 2016 Jun 1;134(6):651-7 [27077667.001]
  • [Cites] Ophthalmic Surg Lasers Imaging Retina. 2016 May 1;47(5):491-5 [27183557.001]
  • [Cites] Am J Ophthalmol. 2015 Sep;160(3):553-560.e3 [26004406.001]
  • [Cites] Arch Ophthalmol. 2002 Nov;120(11):1470-6 [12427059.001]
  • [Cites] J AAPOS. 2011 Dec;15(6):573-8 [22153403.001]
  • [Cites] Arch Ophthalmol. 2010 Sep;128(9):1217-20 [20837812.001]
  • [Cites] Arch Ophthalmol. 1984 Aug;102(8):1130-4 [6547831.001]
  • [Cites] J AAPOS. 2007 Dec;11(6):532-40 [18029210.001]
  • [Cites] Ophthalmology. 2016 Nov;123(11):2345-2351 [27566853.001]
  • [Cites] Arch Ophthalmol. 2011 May;129(5):591-6 [21555612.001]
  • [Cites] JAMA Ophthalmol. 2014 May;132(5):640-4 [24604415.001]
  • [Cites] Arch Ophthalmol. 1988 Apr;106(4):471-9 [2895630.001]
  • [Cites] J AAPOS. 2012 Feb;16(1):1 [22245023.001]
  • [Cites] Methods Inf Med. 2015 ;54(1):93-102 [25434784.001]
  • [Cites] Arch Dis Child Fetal Neonatal Ed. 2013 Mar;98(2):F170-4 [22209748.001]
  • [Cites] J AAPOS. 2012 Apr;16(2):177-81 [22525176.001]
  • [Cites] J AAPOS. 2008 Aug;12(4):352-6 [18329925.001]
  • [Cites] Retina. 2013 Sep;33(8):1700-7 [23538582.001]
  • [Cites] N Engl J Med. 2011 Feb 17;364(7):603-15 [21323540.001]
  • [Cites] Trans Am Ophthalmol Soc. 2007;105:461-80 [18427626.001]
  • [Cites] Arch Ophthalmol. 2009 Jun;127(6):794-8 [19506200.001]
  • [Cites] Am J Ophthalmol. 2012 Mar;153(3):544-551.e2 [22019222.001]
  • [Cites] JAMA Ophthalmol. 2013 Aug;131(8):1026-32 [23702696.001]
  • [Cites] Ophthalmology. 2008 Jul;115(7):1222-1228.e3 [18456337.001]
  • [Cites] Arch Ophthalmol. 2003 Dec;121(12 ):1684-94 [14662586.001]
  • [Cites] Br J Ophthalmol. 2012 Apr;96(4):549-53 [22174097.001]
  • [Cites] Arch Ophthalmol. 2007 Jul;125(7):875-80 [17620564.001]
  • [Cites] J AAPOS. 2000 Aug;4(4):224-9 [10951298.001]
  • [Cites] Retina. 2012 Jun;32(6):1148-55 [22466473.001]
  • [Cites] PLoS One. 2016 Jan 27;11(1):e0148019 [26815000.001]
  • [Cites] Am J Ophthalmol. 2010 Oct;150(4):468-475.e2 [20643397.001]
  • [Cites] Biometrics. 1977 Mar;33(1):159-74 [843571.001]
  • [Cites] Psychol Bull. 1968 Oct;70(4):213-20 [19673146.001]
  • [Cites] Pediatrics. 2016 Apr;137(4):null [27244705.001]
  • [Cites] Pediatrics. 2016 Apr;137(4):null [27244707.001]
  • [Cites] Trans Am Ophthalmol Soc. 2007;105:73-84; discussion 84-5 [18427596.001]
  • (PMID = 28087400.001).
  • [ISSN] 1879-1891
  • [Journal-full-title] American journal of ophthalmology
  • [ISO-abbreviation] Am. J. Ophthalmol.
  • [Language] eng
  • [Grant] United States / NEI NIH HHS / EY / P30 EY010572; United States / NEI NIH HHS / EY / R01 EY019474; United States / NEI NIH HHS / EY / R21 EY022387
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] United States
  • [Investigator] Chiang MF; Ostmo S; Sonmez K; Campbell JP; Chan RV; Jonas K; Horowitz J; Coki O; Eccles CA; Sarna L; Berrocal A; Negron C; Denser K; Cumming K; Osentoski T; Check T; Zajechowski M; Lee T; Kruger E; McGovern K; Simmons C; Murthy R; Galvis S; Rotter J; Chen I; Li X; Taylor K; Roll K; Kalpathy-Cramer J; Erdogmus D; Ioannidis S; Martinez-Castellanos MA; Salinas-Longoria S; Romero R; Arriola A; Olguin-Manriquez F; Meraz-Gutierrez M; Dulanto-Reinoso CM; Montero-Mendoza C
  •  go-up   go-down


10. Saia M, Buja A, Mantoan D, Sartor G, Agresta F, Baldo V: Isolated rectal cancer surgery: a 2007-2014 population study based on a large administrative database. Updates Surg; 2017 Apr 13;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Isolated rectal cancer surgery: a 2007-2014 population study based on a large administrative database.
  • This was a retrospective cohort study based on administrative data collected from 2007 to 2014 in the Veneto region (north-east Italy).
  • In the period considered (2007-2014), 4953 rectal resections were performed for RC in Veneto hospitals, accounting for 35% of the total 14,243 surgical procedures involving the rectum, and resulting in 76,739 days in hospital [mean length of stay-post-operative (MLOS) 15.5 ± 11.1 days].
  • Patients were a mean 67.9 ± 11.7 years old (68 ± 12.7 for women, 67.9 ± 11 for men), while the subgroup of patients undergoing laparoscopic procedures was on average 2 years younger (66.5 ± 11.8 vs 68.8 ± 11.5; p < 0.05).
  • (1) the increasing rates of laparoscopic procedures for RC resection at all the hospitals in our geographical area, rising up to 52% in 2014.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Colorectal Dis. 2012 Dec;14(12):1467-72 [22487101.001]
  • [Cites] Br J Surg. 2013 Sep;100(10):1368-75 [23939849.001]
  • [Cites] World J Gastroenterol. 2014 Dec 28;20(48):18104-20 [25561780.001]
  • [Cites] J Gastrointest Surg. 2016 May;20(5):1056-64 [26831061.001]
  • [Cites] Dis Colon Rectum. 2014 Apr;57(4):415-22 [24608296.001]
  • [Cites] Clin Colon Rectal Surg. 2005 Aug;18(3):174-81 [20011300.001]
  • [Cites] Med J Aust. 2011 May 2;194(9):443-7 [21534898.001]
  • [Cites] Mol Clin Oncol. 2014 Nov;2(6):1097-1102 [25279204.001]
  • [Cites] Aging Dis. 2015 Mar 10;6(2):149-55 [25821642.001]
  • [Cites] Surg Endosc. 2007 Jul;21(7):1063-8 [17484010.001]
  • [Cites] J Natl Cancer Inst. 2014 Dec 19;107(1):362 [25527640.001]
  • [Cites] Ann Surg. 2005 Dec;242(6):890-5, discussion 895-6 [16327499.001]
  • [Cites] Dis Colon Rectum. 2013 Jun;56(6):679-88 [23652740.001]
  • [Cites] Orthopade. 2009 Dec;38(12):1160-70 [19844692.001]
  • [Cites] Dis Colon Rectum. 2009 Oct;52(10):1695-704 [19966600.001]
  • [Cites] Int J Colorectal Dis. 2014 Jul;29(7):863-75 [24820678.001]
  • [Cites] J Minim Access Surg. 2006 Dec;2(4):205-10 [21234147.001]
  • [Cites] Diabetologia. 2008 Nov;51(11):1962-70 [18719880.001]
  • [Cites] Lancet. 2013 Sep 28;382(9898):1121-9 [24075052.001]
  • [Cites] Hippokratia. 2007 Oct;11(4):175-7 [19582189.001]
  • [Cites] Chirurg. 2012 Oct;83(10):923-33; quiz 934 [22895649.001]
  • [Cites] Lancet Oncol. 2013 Mar;14(3):210-8 [23395398.001]
  • [Cites] Oper Orthop Traumatol. 2011 Oct;23(4):254-64 [21922231.001]
  • [Cites] World J Surg. 2013 Mar;37(3):646-51 [23188532.001]
  • [Cites] Ann Surg Oncol. 2006 Mar;13(3):413-24 [16450220.001]
  • [Cites] Br J Surg. 2013 Mar;100(4):553-60 [23288592.001]
  • (PMID = 28409441.001).
  • [ISSN] 2038-3312
  • [Journal-full-title] Updates in surgery
  • [ISO-abbreviation] Updates Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  • [Keywords] NOTNLM ; Laparoscopic surgery / Rectal cancer surgery / Rectal surgery technique population-based study / Surgical outcomes
  •  go-up   go-down